Pharmaceuticals, Biotechnology and Life Sciences
DUBLIN–(BUSINESS WIRE)–The “Dermatitis Drugs Global Market Report 2020” report has been added to ResearchAndMarkets.com’s offering. Where is the largest and…
TRUXIMA Available Week of November 11 JERUSALEM & PARSIPPANY, N.J. & INCHEON, South Korea–(BUSINESS WIRE)–Teva Pharmaceuticals USA, Inc., a U.S.…
JERUSALEM–(BUSINESS WIRE)–Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) announced today the appointment of Eli Kalif as Executive Vice President…
Revenues of $4.3 billion GAAP diluted loss per share of $0.29 Non-GAAP diluted EPS of $0.58 Free cash flow of…
–First Evidence of Long-Term Improvement and Stabilization in Blood Counts and Durable Mosaicism in RP-L102 “Process A” for Fanconi Anemia–…
Conference Call Scheduled Today at 8:30 a.m. ET LEXINGTON, Mass.–(BUSINESS WIRE)–$CNCE #CNCE—Concert Pharmaceuticals, Inc. (NASDAQ: CNCE) today reported financial results…
DUBLIN–(BUSINESS WIRE)–The “Cell Analysis Market by Product [Microscope, Spectrophotometers, Flow cytometry (Software, Accessories)], Process (Cell Viability, Cell Proliferation, Signal Transduction),…
Received orphan drug designation from the European Commission for mavorixafor for treatment of WHIM Syndrome Reported positive data from Phase…
WALTHAM, Mass.–(BUSINESS WIRE)–Palleon Pharmaceuticals, a leading biotech company developing drugs that target the Siglec-Sialoglycan axis to treat cancer, today announced…
CAMBRIDGE, Mass.–(BUSINESS WIRE)–AVEO Oncology (NASDAQ: AVEO) and Biodesix, Inc. today announced the initiation of the CyFi-2 study, a randomized Phase…